Clay joined OrbiMed in 2021 and is a Vice President focused on medical technology and other non-therapeutics areas of venture-stage investing. Prior to joining OrbiMed, Clay was a Vice President on the medical technology Equity Research team at BofA Securities. Prior to Equity Research, Clay was an Investment Banking Associate in the healthcare group at BofA Securities. Previously, Clay also worked in management consulting with Accenture Strategy as part of the Operations practice. Clay received a B.Sc. from Vanderbilt University and his M.B.A from Emory University’s Goizueta Business School. Outside the office, Clay can be found enjoying NY, spending time with friends and family, or thinking about chips and salsa.